Aurobindo Pharma receives USFDA approvals for two drugs
Brand India Pharma | January 03, 2017
Aurobindo Pharma Limited has received US Food &Drug Administration (USFDA) approval to make and market heartburn relief medicine Famotidine tablets of strengths 10 mg and 20 mg and Oxymorphone Hydrochloride Tablets of strengths 5 mg and 10 mg . The estimated market size for Famotidine for the 12 month period ending February 2016 was US$ 31 million whereas for Oxymorphone Hydrochloride Tablets, it is US$ 55.5 million for the same period as per data by IMS.